Prognostic significance of APOBEC1 and its role in lung squamous cell carcinoma: insights from chromatin regulator-based modeling and experimental validation
- Min Liang 1,2, Chaohao Zhang 3, Shengming Liu 4
- Min Liang 1,2, Chaohao Zhang 3, Shengming Liu 4
- 1Jinan University, Guangzhou, China.
- 2Department of Respiratory and Critical Care Medicine, Maoming People's Hospital, Maoming, China.
- 3Department of Pathology, Maoming People's Hospital, Maoming, China.
- 4Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Jinan University, Guangzhou, China.
- 0Jinan University, Guangzhou, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study developed a prognostic model using eight chromatin regulators (CRs) for lung squamous cell carcinoma (LUSC). The model predicts patient survival and identifies APOBEC1 as a potential therapeutic target in LUSC.
Area Of Science
- Oncology
- Molecular Biology
- Genomics
Background
- Chromatin regulators (CRs) play a role in cancer development.
- The prognostic significance of CRs in lung squamous cell carcinoma (LUSC) is not well understood.
- APOBEC1's role in LUSC progression requires further investigation.
Purpose Of The Study
- To develop a prognostic model for LUSC based on chromatin regulators.
- To explore the prognostic value of these regulators in LUSC.
- To investigate the role of APOBEC1 in LUSC progression and its potential as a therapeutic target.
Main Methods
- Analysis of transcriptomic and clinical data from TCGA and GEO databases.
- Identification of prognostic CRs using univariate Cox and Lasso regression analyses.
- Experimental validation of APOBEC1 function in LUSC cell lines using in vitro assays.
Main Results
- An eight-gene CR-based signature demonstrated strong prognostic performance across multiple datasets (5-year AUCs 0.73-0.92).
- High-risk patients exhibited enrichment in cancer pathways, increased immune infiltration, and sensitivity to specific drugs (Dasatinib, Bexarotene, Bicalutamide).
- APOBEC1 was found to be overexpressed in LUSC and promoted cancer cell proliferation and migration.
Conclusions
- A robust CR-based prognostic model for LUSC survival was established.
- APOBEC1 is identified as a potential therapeutic target for LUSC.
- This research provides insights into the molecular mechanisms of LUSC and potential therapeutic strategies.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

